StockData

Akso Health vs Concorde International

AHG and CIGL side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AHG and CIGL compare

Concorde International grew revenue faster over the last twelve months (18.9% versus −6.4% for Akso Health).

Concorde International keeps more of each dollar of sales as profit, with a net margin of −122% compared with −135% at Akso Health.

Akso Health scores higher on the StockData Score (7 against 4 for Concorde International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAHGCIGL
Size and price
Share price$1.33$0.220
Change, 1 year−9.5%−89.8%
Change, 5 years−55.2%–
Beta (5Y)−2.212.60
Employees12109
StockData Score
Total score7 (better)4
Valuation score00
Growth score12 (better)
Performance score11
Health score5 (better)1
Dividend score00
Growth
Revenue growth (TTM)−6.4%18.9% (better)
Revenue growth, 5Y average51.1%–
EPS growth (TTM)−93.8%–
Profitability
Gross margin−0.08%30.8% (better)
Operating margin−150%–
Net margin−135%−122% (better)
FCF margin−92.5%−29.7% (better)
Return on equity−9.8% (better)−535%
Return on invested capital−16.1%–
Financial health
Debt / equity0.000.66 (better)
Current ratio21.77 (better)1.28
Piotroski F-score5 (better)4
Ownership
Held by institutions0.01%–
Held by insiders0.00%67.7%
Short interest, % of float–3.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.